State documents show UNC president didn't report board seats

By  | 

RALEIGH, N.C. (AP) - Records obtained by a North Carolina news outlet show the interim president of the University of North Carolina system and former CEO of the UNC Health Care System failed to disclose his seats on the boards of major corporations while those corporations did business with the state.

WBTV reports it obtained records from 2011 to 2019 that reveal William Roper serves on the UNC Health Care System board as well as having served on the DaVita, Inc. board and the boards of three successor companies in pharmacy benefits administration.

Records show Roper made around $5 million from his board involvements. The omissions on Roper's forms came as some of the companies conducted business with the state.

Roper stated he recuses himself from matters that might pose a conflict of interest and has filed amended forms.

(Copyright 2019 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)


UNC Board of Governors Chairman Harry Smith Issues Statement

CHAPEL HILL, NC – University of North Carolina Board of Governors Chairman Harry Smith issued the following statement:

‘Dr. Bill Roper’s public board service was well known during his time as CEO of the UNC Health Care System. That information was available to the general public on the Health Care System’s public website and open to examination in public filings with and evaluations by the Securities and Exchange Commission. Dr. Roper also fully disclosed his board service to us when the Board of Governors appointed him as interim president and received authorization to continue his service.

We have reviewed this matter and we are aware of no instance in which Dr. Roper ever involved himself in a decision that presented a conflict. In fact, documents produced by the UNC Health Care System demonstrate that he was careful to avoid any conflicts. We have also received confirmation of the State Ethics Commission’s recent evaluation of Dr. Roper’s statement of economic interest in which the commission staff clearly acknowledged Dr. Roper’s disclosure of his board service and interests in two public companies. As is standard practice, the State Ethics Commission advised Dr. Roper to do as he has always done, which is to exercise caution and avoid conflicts in any instance where the interests of those companies come before the UNC System or the UNC Health Care System. We are in full support of Dr. Roper and look forward to his continued service to the UNC System.’